Detalhe da pesquisa
1.
Mutational profiles of metastatic colorectal cancer treated with FOLFIRI plus cetuximab or bevacizumab before and after secondary resection (AIO KRK 0306; FIRE-3).
Int J Cancer
; 149(11): 1935-1943, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34310714
2.
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial.
Eur J Cancer
; 190: 112955, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37454537
3.
Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212).
J Clin Oncol
; 41(16): 2975-2987, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37018649
4.
Follow-up lung ultrasound to monitor lung failure in COVID-19 ICU patients.
PLoS One
; 17(7): e0271411, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35834575
5.
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
Front Oncol
; 12: 751453, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35251955
6.
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023.
Oncol Res Treat
; 47(4): 149-153, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38417407